Evaluation of berberine pellet effect on clinical recovery time in COVID-19 outpatients: A pilot clinical trial.
Berberine, a medicinal compound with analgesic, anti-asthmatic, anti-inflammatory, and antiviral properties, was studied for its effect on COVID-19 outpatients. Understanding its impact could provide insights into treating respiratory distress syndrome caused by severe COVID-19.
- Omidvar Tehrani S et al (2023).
- Avicenna J Phytomed.
- PubMed:
- 37654997